Amarin Corp Plc (AMRN)

[Jasbg]

Please can any of the Law people answer a couple of very simple questions about the Patern case - Hikma and Reddy - I have been searching for since yesterday:

1. Who sued Who ? Was it Amarin that started the lawsuit or was it the generic's ?

2. If it was Amarin 'starting the case' - it must have been to stop generic's in an already stated proces to make a generic version of Vascepa ?

3. If Hikma and Reddy was on the brink of producing generic version of Vascepa - there must have been some patents 'running out' earlier than the ones handeled in the Teva deal (2029) ?
------------------

Can someone please clear up these basic points of the patent trial ?

Why were Hikma and Reddy in the 'first place' planing generic version af Vascepa - unless some patents were running out ?

(Think I understand the later part of the case - Amarin make 'new patents' protecting R-I results - and 'therefore now generics - should not be aloud to make generis version - which the judge overruled)
------------------

It's the facts about the start of the proces I'm confused about - would very much have cleared up.

Thanks in advance to anyone who can explain 'the basis for Hikma and Reddy - in the first place would be planing a generic version of Vascepa (before the R-I run later) ?

Jasbg